Welcome to our dedicated page for Roper Techno SEC filings (Ticker: ROP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how each new acquisition changes Roper Technologies鈥� cash flow is tough鈥攖he annual report alone folds niche SaaS metrics, engineered products margins, and purchase-price allocations into hundreds of pages. If you have ever asked 鈥淲here can I find Roper Technologies鈥� quarterly earnings report 10-Q filing?鈥� or 鈥淲hat do Roper Technologies insider trading Form 4 transactions tell me?鈥� you already know the challenge.
Stock Titan solves it. Our AI reads every 10-K, 10-Q, 8-K and proxy statement the moment it posts to EDGAR, then translates the legal language into plain English. Need to see goodwill created by the latest medical-software buyout, or monitor a sudden spike in deferred revenue? You鈥檒l get an AI-powered summary, key ratios, and red-flag alerts within seconds. AG真人官方-time notifications surface Roper Technologies Form 4 insider transactions the instant executives trade, while side-by-side charts compare segments across filings so you can spot margin shifts without scrolling through PDFs.
All filing types are here: the annual report 10-K simplified for segment cash generation, the proxy statement with executive compensation tables, each 8-K material event explained, plus every Roper Technologies quarterly earnings report 10-Q filing annotated for backlog and SaaS renewal trends. Whether you鈥檙e evaluating free cash flow quality, tracking acquisition earn-outs, or simply wanting understanding Roper Technologies SEC documents with AI, this page delivers concise insights professionals rely on鈥攏o more digging through footnotes.
Safe & Green Holdings Corp. (Nasdaq: SGBX) has filed Amendment No. 3 to its Form S-1 to register 20,408,160 common shares for resale by a single selling stockholder. The shares comprise 2,504,040 common shares and 17,904,120 shares underlying $0.0001 pre-funded warrants issued in an April 14 2025 private placement that generated roughly $8 million gross. The company will receive no proceeds from the resale, and only 鈮�$20,408 if all pre-funded warrants are exercised in cash; those funds and the April placement proceeds are earmarked for working capital.
SGBX remains a smaller reporting company and has faced repeated Nasdaq deficiencies. A July 8 2025 Hearings Panel decision allows continued listing provided the firm effects a reverse split (1-for-10 to 1-for-100) and sustains a 鈮�$1.00 bid for 10 consecutive days by Aug 28 2025. A shareholder vote is set for Aug 25 2025.
Liquidity moves in 2025: (i) $2 million secured revolver at 5% with Prosperity Bank; (ii) up to $100 million equity line with Generating Alpha Ltd.; (iii) $267 k OID note at 15% convertible on default; (iv) $1 million County Line and $1 million Sherman Oil asset purchases; (v) planned merger with New Asia Holdings to add 鈮�$35 million to equity. April Series A/B warrants were exchanged for 60,000 Series B preferred shares to ease Nasdaq dilution concerns.
Post-offering common shares outstanding, assuming full warrant exercise, would rise to 30,024,771 versus 12,120,651 currently, excluding additional options, warrants, RSUs and 300 million shares underlying Series B preferred.
Encompass Capital Advisors LLC and its managing member Todd J. Kantor have filed a Schedule 13G reporting a passive ownership of 5,206,191 Sable Offshore Corp. common shares, representing 5.24 % of the outstanding class as of 17 Jul 2025 (CUSIP 78574H104).
The filing shows shared voting and dispositive power over the entire position and no sole authority. Encompass is classified as an investment adviser (IA), while Kantor is listed as both a control person (HC) and individual (IN). The certification affirms the stake was not acquired to change or influence control of the issuer.
Crossing the 5 % threshold triggers this disclosure under Rule 13d-1; however, no additional financial data, governance proposals, or transactional intentions are provided.
Sun Communities (NYSE: SUI) filed an 8-K announcing a leadership transition.
- Charles D. Young, former President of Invitation Homes, will become Chief Executive Officer and join the Board on 1 Oct 2025, enlarging the Board to ten members.
- 驰辞耻苍驳鈥檚 5-year employment agreement sets a $900k base salary and a target annual cash bonus equal to 200 % of salary (2025 bonus guaranteed at target, prorated).
- On the start date he will receive equity and cash inducements designed to replace forfeited Invitation Homes awards: $3.55 m performance-based RS, $1 m fully-vested stock, $4 m time-vested RS, a $750k cash bonus and $300k relocation benefits. A 2026 equity award worth $6 m is also committed.
- Severance for termination without cause or resignation for good reason equals 2脳 salary plus target bonus and accelerated vesting; change-in-control multiple is 2.99脳.
- Gary A. Shiffman will retire as CEO when Young starts and remain Non-Executive Chairman through the 2026 AGM.
No disagreements or related-party transactions were reported. Exhibit 99.1 contains the related press release.
Form 144 filing: An unidentified insider of Roper Technologies (ROP) intends to sell up to 1,500 common shares on or about 07/23/2025 through Fidelity Brokerage Services. The proposed transaction is valued at $846,255.15 and represents roughly 0.001% of the 107.5 million shares outstanding, indicating an immaterial portion of the equity float.
The shares originate from an option granted on 06/09/2017 and will be acquired for cash immediately prior to sale. No other insider sales were reported during the past three months. By signing, the seller certifies possession of no undisclosed adverse information about Roper鈥檚 operations.
Ikena Oncology (IKNA) filed an 8-K announcing its board has declared a one-time special dividend of one contingent value right (CVR) for every outstanding share held as of the close of business on 24 Jul 2025. The CVRs are being issued in connection with the previously disclosed two-step merger with Inmagene Biopharmaceuticals.
Under the contemplated CVR Agreement, holders will receive (i) 100% of net proceeds, if any, from milestone, royalty or earn-out payments tied to dispositions of IKNA鈥檚 pre-merger assets and (ii) 90% of net proceeds from dispositions executed within one year after closing, both after permitted deductions (taxes, expenses, litigation and wind-down costs). If no such proceeds arise during the CVR term, the CVRs will expire worthless.
The merger structure remains unchanged: Merger Sub I merges into Inmagene, followed immediately by Inmagene into Merger Sub II, creating a wholly-owned subsidiary of IKNA. Forward-looking statements caution that closing conditions, expense control, legal proceedings and asset-sale milestones may affect both the merger and any CVR payout.
FAQ
What is the current stock price of Roper Techno (ROP)?
What is the market cap of Roper Techno (ROP)?
What is the core business of Roper Technologies?
How does Roper Technologies generate revenue?
What industries does Roper Technologies serve?
How is the operational model of Roper Technologies structured?
What distinguishes Roper Technologies in the competitive landscape?
What is Roper's approach to acquisitions?
How does Roper Technologies maintain its market presence?
Why is Roper Technologies included in major indices?
